Annie Huang

18.2k total citations
127 papers, 3.8k citations indexed

About

Annie Huang is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Annie Huang has authored 127 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 66 papers in Genetics and 31 papers in Neurology. Recurrent topics in Annie Huang's work include Glioma Diagnosis and Treatment (66 papers), Chromatin Remodeling and Cancer (35 papers) and Neuroblastoma Research and Treatments (27 papers). Annie Huang is often cited by papers focused on Glioma Diagnosis and Treatment (66 papers), Chromatin Remodeling and Cancer (35 papers) and Neuroblastoma Research and Treatments (27 papers). Annie Huang collaborates with scholars based in Canada, United States and United Kingdom. Annie Huang's co-authors include Éric Bouffet, Ute Bartels, Cynthia Hawkins, Uri Tabori, Lucie Lafay‐Cousin, Yuntao Lu, Songtao Qi, Timothy W. Corson, Bryan Williams and Herman Yeger and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Annie Huang

122 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Huang Canada 35 2.3k 1.4k 793 555 541 127 3.8k
Theo J.M. Hulsebos Netherlands 32 2.0k 0.9× 853 0.6× 996 1.3× 526 0.9× 533 1.0× 87 3.6k
Ryuya Yamanaka Japan 32 1.3k 0.6× 806 0.6× 444 0.6× 386 0.7× 351 0.6× 110 3.5k
Timothy T. Stenzel United States 25 1.6k 0.7× 1.5k 1.1× 316 0.4× 464 0.8× 923 1.7× 45 3.8k
Reiner Siebert Germany 34 1.6k 0.7× 778 0.5× 340 0.4× 377 0.7× 276 0.5× 144 3.3k
José I. Martı́n-Subero Spain 43 2.9k 1.3× 1.4k 1.0× 359 0.5× 1.3k 2.3× 298 0.6× 147 5.7k
J. Reifenberger Germany 35 2.8k 1.2× 1.3k 0.9× 317 0.4× 755 1.4× 410 0.8× 100 4.7k
Finbarr E. Cotter United Kingdom 38 2.6k 1.2× 872 0.6× 235 0.3× 331 0.6× 516 1.0× 111 5.0k
Marcus B. Valentine United States 26 1.7k 0.7× 322 0.2× 454 0.6× 415 0.7× 795 1.5× 39 3.6k
Akiko Shimamura United States 40 4.0k 1.8× 625 0.4× 130 0.2× 498 0.9× 207 0.4× 128 6.6k
Hideo Takeshima Japan 25 765 0.3× 625 0.4× 511 0.6× 219 0.4× 317 0.6× 123 2.3k

Countries citing papers authored by Annie Huang

Since Specialization
Citations

This map shows the geographic impact of Annie Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Huang more than expected).

Fields of papers citing papers by Annie Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Huang. The network helps show where Annie Huang may publish in the future.

Co-authorship network of co-authors of Annie Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Huang. A scholar is included among the top collaborators of Annie Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Huang. Annie Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasslocher‐Moreno, Alejandro Marcel, Vijay Ramaswamy, Anirban Das, et al.. (2025). Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma. Radiotherapy and Oncology. 207. 110865–110865.
2.
Mazewski, Claire, Sarah Leary, Guolian Kang, et al.. (2025). Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group. Neuro-Oncology. 27(10). 2726–2737. 3 indexed citations
3.
Ho, Beng‐Choon, Anthony Arnoldo, Yunan Zhong, et al.. (2024). Rapid, economical diagnostic classification of ATRT molecular subgroup using NanoString nCounter platform. Neuro-Oncology Advances. 6(1). vdae004–vdae004.
4.
Urban, Jennifer A., et al.. (2023). Sex-specific splicing occurs genome-wide during early Drosophila embryogenesis. eLife. 12. 6 indexed citations
5.
Lindsay, Holly, Sylvia Cheng, Paul G. Fisher, et al.. (2023). Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group. Neuro-Oncology Advances. 5(1). vdad130–vdad130. 1 indexed citations
7.
Mishra, Deepak Kumar, Shelli M. Morris, Shiva Senthil Kumar, et al.. (2023). Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward. Neuro-Oncology. 26(2). 226–235. 1 indexed citations
8.
Mishra, Deepak Kumar, Shelli M. Morris, Shiva Senthil Kumar, et al.. (2023). IMMU-11. PRECLINICAL HIGH-RISK PEDIATRIC BRAIN TUMOR MODELS FOR IMMUNOTHERAPY: HURDLES AND THE WAY FORWARD. Neuro-Oncology. 25(Supplement_1). i51–i52. 1 indexed citations
9.
Hamid, Syed Ahmer, Nida Zia, Uri Tabori, et al.. (2022). Impact of dedicated pediatric neuro‐oncological services in a developing country: A single‐institution, Pakistani experience. Pediatric Blood & Cancer. 69(11). e29887–e29887. 11 indexed citations
10.
Chan, Tiffany Sin Yu, Daniel Picard, Cynthia Hawkins, et al.. (2021). Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma. Neuro-Oncology Advances. 3(1). vdab002–vdab002. 4 indexed citations
11.
Baroni, Lorena, Daniel Alderete, Palma Solano‐Páez, et al.. (2020). Bevacizumab for pediatric radiation necrosis. Neuro-Oncology Practice. 7(4). 409–414. 13 indexed citations
12.
Li, Junjie, Lei Chen, Songtao Qi, et al.. (2019). HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma. Clinical Cancer Research. 25(12). 3602–3616. 82 indexed citations
13.
Tsang, Derek S., Vijay Ramaswamy, Liana Nobre, et al.. (2019). Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience. Journal of Neuro-Oncology. 145(1). 107–114. 14 indexed citations
14.
Tsang, Derek S., Éric Bouffet, Cynthia Hawkins, et al.. (2019). Repeat irradiation for children with supratentorial high‐grade glioma. Pediatric Blood & Cancer. 66(9). e27881–e27881. 12 indexed citations
15.
Lassaletta, Álvaro, Douglas Strother, Normand Laperrière, et al.. (2018). Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience. Pediatric Blood & Cancer. 65(6). e26988–e26988. 54 indexed citations
16.
Chan, Tiffany Sin Yu, Cynthia Hawkins, Jonathan R. Krieger, C. Jane McGlade, & Annie Huang. (2016). JPO2/CDCA7L and LEDGF/p75 Are Novel Mediators of PI3K/AKT Signaling and Aggressive Phenotypes in Medulloblastoma. Cancer Research. 76(9). 2802–2812. 20 indexed citations
18.
Zhou, Limei, Daniel Picard, Young‐Shin Ra, et al.. (2010). Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma. Cancer Research. 70(20). 8199–8210. 47 indexed citations
19.
Gassas, Adam, Donald Mabbott, Annie Huang, et al.. (2010). Atypical Teratoid or Rhabdoid Tumors: Improved Outcome With High-dose Chemotherapy. Journal of Pediatric Hematology/Oncology. 32(5). e182–e186. 52 indexed citations
20.
Huang, Annie, Cynthia S.W. Ho, Romina Ponzielli, et al.. (2005). Identification of a Novel c-Myc Protein Interactor, JPO2, with Transforming Activity in Medulloblastoma Cells. Cancer Research. 65(13). 5607–5619. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026